Series B - Novadip Biosciences
Investment Firm
Overview
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Announced Date
Nov 03, 2022
Funding Type
Series B
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
5
Round Details and Background
Novadip Biosciences raised $23398518 on 2022-11-03 in Series B
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 28, 2021 |  Series B - Novadip Biosciences | 7 | - | 22.2M |
| Nov 03, 2022 | Series B - Novadip Biosciences | 8 | - | 23.4M |
| Nov 03, 2022 | Grant - Novadip Biosciences | - | 15.6M | |
| Sep 10, 2015 | Series A - Novadip Biosciences | 5 | - | 31.6M |
Recent Activity
There is no recent news or activity for this profile.